Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2788
Source ID: NCT00108004
Associated Drug: Pramlintide Acetate
Title: Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type 1 Diabetes Mellitus|Type 2 Diabetes Mellitus
Interventions: DRUG: pramlintide acetate
Outcome Measures: Primary: To investigate the clinical utility and safety of pramlintide in subjects with type 1 and type 2 diabetes mellitus, To investigate the clinical utility (change in HbA1c, seven-point glucose profile, body weight, and insulin use) and safety of pramlintide in subjects with type 1 and type 2 diabetes mellitus who have not achieved glycemic targets with insulin therapy., 6 months|Understand management issues in subjects with type 1 and type 2 diabetes mellitus, To collect data regarding the selection of subjects for pramlintide administration by healthcare professionals and to further understand management issues in subjects with type 1 and type 2 diabetes mellitus who have not achieved glycemic targets with insulin therapy, 6 months |
Sponsor/Collaborators: Sponsor: AstraZeneca
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 400
Study Type: INTERVENTIONAL
Study Designs: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2003-04
Completion Date: 2005-06
Results First Posted:
Last Update Posted: 2015-05-21
Locations: Research Site, Anaheim, California, United States|Research Site, Escondido, California, United States|Research Site, La Jolla, California, United States|Research Site, Los Gatos, California, United States|Research Site, San Francisco, California, United States|Research Site, Torrance, California, United States|Research Site, New Britain, Connecticut, United States|Research Site, Norwalk, Connecticut, United States|Research Site, Norwich, Connecticut, United States|Research Site, Washington, District of Columbia, United States|Research Site, Clearwater, Florida, United States|Research Site, Orlando, Florida, United States|Research Site, Columbus, Georgia, United States|Research Site, Honolulu, Hawaii, United States|Research Site, Idaho Falls, Idaho, United States|Research Site, Indianapolis, Indiana, United States|Research Site, Vincennes, Indiana, United States|Research Site, Topeka, Kansas, United States|Research Site, Wichita, Kansas, United States|Research Site, Lexington, Kentucky, United States|Research Site, Baltimore, Maryland, United States|Research Site, Bloomfield Hills, Michigan, United States|Research Site, Tupelo, Mississippi, United States|Research Site, Las Vegas, Nevada, United States|Research Site, Reno, Nevada, United States|Research Site, Moorestown, New Jersey, United States|Research Site, Neptune, New Jersey, United States|Research Site, Roseland, New Jersey, United States|Research Site, New York, New York, United States|Research Site, Williston Park, New York, United States|Research Site, Yonkers, New York, United States|Research Site, Greenville, North Carolina, United States|Research Site, Lakewood, Ohio, United States|Research Site, Westlake, Ohio, United States|Research Site, Portland, Oregon, United States|Research Site, Philadelphia, Pennsylvania, United States|Research Site, Wilkes Barre, Pennsylvania, United States|Research Site, Charleston, South Carolina, United States|Research Site, Sumter, South Carolina, United States|Research Site, Chattanooga, Tennessee, United States|Research Site, Knoxville, Tennessee, United States|Research Site, Memphis, Tennessee, United States|Research Site, Nashville, Tennessee, United States|Research Site, Arlington, Texas, United States|Research Site, Dallas, Texas, United States|Research Site, Olympia, Washington, United States|Research Site, Madison, Wisconsin, United States|Research Site, Milwaukee, Wisconsin, United States
URL: https://clinicaltrials.gov/show/NCT00108004

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress